IQVIA Oncology Dynamics (Colombia)

Field Names
Records
Coordinating Country
Colombia
Region
Colombia

(All regions of Colombia)

Brief Database Description

IQVIA Oncology Dynamics (Colombia), established in 2020, contains complete patient oncology treatment information collected directly from physicians via a web-based questionnaire. It is an oncology-specific database with drug-treated patients with one of the following indications:  
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.

The database is updated twice a year and has diagnosis, drug, and procedure data. To date it has close to 7,000 patients.

The Colombian dataset is a part of the IQVIA Oncology Dynamics portfolio. The full portfolio is a global database comprising patient records spanning 22 countries:
- Australia
- Austria
- Belgium
- Brazil
- Bulgaria
- China
- Colombia
- Czech Republic
- France
- Germany
- India
- Italy
- Japan
- Mexico
- Romania
- Saudi Arabia
- Slovakia
- South Korea
- Spain
- Turkey
- United Kingdom
- USA

Database Type
Cross-sectional Population Data
- Population Surveys - specific (selected diseases/or all drugs)

IQVIA Oncology Dynamics (Colombia), established in 2020, contains complete patient oncology treatment information collected directly from physicians via a web-based questionnaire. It is an oncology-specific database with drug-treated patients with one of the following indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.

Database Source
Medical Records

(Survey-based, i.e., complete patient oncology treatment information is collected directly from physicians via a web questionnaire.)

Frequency of Data Collection
Ongoing
Frequency of Data Update
Biannually (2X a year)

(Twice a year)

Years Covered
2020 - Present
Population Type
Outpatient/Non-Institutionalized
Inpatient

The database consists of drug-treated patients with one of the following indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.

Patient Type
Inpatient and Outpatient

The database consists of drug-treated patients with one of the following indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.

Date of Last Update
Ongoing

The IQVIA Oncology Dynamics (Colombia) database is updated twice a year.
This profile was developed for the B.R.I.D.G.E. TO DATA site on September 10, 2025.

Field Names
Records
Database Population Size
<200,000

There are a total of 6,843 patients to date

Active Population Size
<200,000

There are a total of 775 active oncology drug-treated patients

Annual Change in Population
N/A

(Not applicable)

Sample Weights - Extrapolation Factors
No

The sample is not weighted in any way. It is meant to give a representative view of the treated prevalent cancer population.

Final Population Size
N/A

(Not applicable, as data collection is still ongoing)

Field Names
Records
Age of Patients at Data Collection
Yes
Approximate Percentage of Participants <18 years and those >65 years

N/A

(Not available; please contact database manager for information)

Gender Data
Yes
Percentage of Males/Females

N/A

(Not available; please contact database manager for information)

Ethnicity / Race Data
No

Ethnicity/race data are not collected

Geographic Location

All areas of Colombia

Date of Birth Recorded
Yes

(Year)

Death Recorded
No
Availability of death certificate / autopsy information
N/A

(Not applicable)

Other Demographic Data
No
Field Names
Records
Physician ID
No
Physician Specialty
Yes
Pharmacy ID
N/A

(Not applicable)

Field Names
Records
Diagnosis Data
Yes
Diagnoses Coded
ICD-10
Diagnoses: Date Parameters
2020 - Present
Diagnoses: Maximum Number of Codes Allowed
1

(Only one - primary cancer diagnosis is listed)

Physical Examination Findings
Yes
Birth Defect Data
No
Cancer Data
Yes

This is an oncology-specific database with drug-treated patients with one of the following (cancer) indications:
- Since Q3/2024: Breast, NSCLC and Prostate
- Historically: Breast, cervix uteri, colorectal, melanoma, NSCLC, ovarian, prostate, ALL, AML, CLL, CML, multiple myeloma & malign plasma cell.

Infectious Disease Data
No
Environmental Exposures
No
Behavioral Data Elements
N/A

(This information is not available; please contact the database manager for details.)

Field Names
Records
Procedure Data
Yes

Information on drug treatment is available

Procedures Coded
ICD-10
Number of Procedures Coded
Unlimited
Procedure Date Parameters
2020 - Present
Laboratory Information
Yes
Field Names
Records
Drug Data
Yes

Data are available on: Treatment dates, molecule level, brand name, posology or daily dose, length of prescription, side effects/adverse events, reason for discontinuation of treatment, cycles planned vs. given; duration of prior line of therapy

Drug Date Parameters
2020 - Present

Data are available on treatment dates

Drug Regimen & Route
N/A

(This information is not available - please contact database manager.)

Drug Manufacturer
Yes

Brand name is available

Drug Dosage
Yes

Posology or daily dose information is available

Drug Days Supply
Yes

Information is available on length of prescription

Drug Coding System: Maximum Number
Unlimited
Drug Coding System: Primary
ATC-EPhMRA/IPMRG
Drug Coding System: Other
N/A

(Not applicable)

Drug Generic Name
N/A

(This information is not available; please contact the database manager for details.)

Drug Additional Information
Yes

Information is available on:
- Side effects/adverse events
- Reason for discontinuation of treatment
- Cycles planned vs. given
- Duration of prior line of therapy
- Molecule level

Field Names
Records
Biobank Type
N/A
Human Specimen
N/A
Blood Type
N/A
Biomarkers
N/A
Patient ID
N/A
Number of Samples
N/A
Frequency of Sample Collection
N/A
Pre-diagnostic Sample Collection
N/A
Post-treatment Sample Collection
N/A
Method of Sample Collection
N/A
Age at Sample Collection
N/A
Date of Sample Collection
N/A
Reason for Sample Collection
N/A
Method of Sample Storage
N/A
Length of Sample Storage
N/A
Pathology
N/A
DNA Isolation
N/A
RNA Isolation
N/A
Cell Culture
N/A
Genetic Testing
N/A
Access for Research: Specimens
N/A
Access for Research: Genetic Data
N/A
Access for Research: Epidemiologic Data
N/A
Quality Assurance Procedures
N/A
Family History
N/A
Medical History
N/A
Biobank Linkage
N/A
Field Names
Records
Type of Genetic Database
N/A
Source of Genetic Data
N/A
Specimen Genotyped
N/A
Tissue Form
N/A
Genetic Template
N/A
Gene-Drug Response
N/A
Gene-Disease Relationship
N/A
Gene-Health Outcome Relationship
N/A
Gene-Environment Response
N/A
Method of Imputing Genetic Data
N/A
Genetic Variant Identification
N/A
Genetic Data Level
N/A
Genotyping Method
N/A
Method of Genetic Variant Filtering
N/A
Haplotypes
N/A
Haplogroups
N/A
Variable Number of Tandem Repeats (VNTR)
N/A
Single Nucleotide Polymorphisms (SNPs)
N/A
Variant Type
N/A
Variant Class
N/A
Mutation Indicated
N/A
Position
N/A
Amino Acid Change
N/A
Genotype / Polymorphism
N/A
Allele Frequency
N/A
Linkage Disequilibrium (r²)
N/A
Noncarriers Indicated
N/A
Association Statistics
N/A
Genetic Relatedness Pairing
N/A
Data Sharing: Genetic Data
N/A
Access for Research
N/A
Genetic Data Linkage
N/A
Description of Genetic Data Linkage
N/A
Field Names
Records
Cost Data
No
Cost Denomination
N/A

(Not applicable)

Type of Cost Data
N/A

(Not applicable)

Description of Surrogate Link
N/A

(Not applicable)

Field Names
Records
Data Validation Against Original Source
No

However, numerous quality checks are performed on the data collected to ensure accuracy

Access to Medical Records
No
Linkage to Other Databases
Yes

Linkage does exist

Brief Description of Linkage Capabilities

All Oncology Dynamics databases are linked; however, they are not linked to other IQVIA Health databases. Please contact database manager for details.

Field Names
Records
Database Contact Data

Email: RWDassets@iqvia.com

Alternate Contact

N/A

(Not applicable)

Source of Database Funding
Private

(IQVIA)

Sponsoring Government Agency
N/A

(Not applicable)

Sponsoring Pharmaceutical Manufacturer

N/A

(Not applicable)

Database Usage Restrictions
Private Access

This is a subscription database available to the pharmaceutical industry. Interested clients should contact email RWDassets@iqvia.com for more information regarding access.

Charge for Database Usage
Yes

Please email database contact mentioned above regarding costs related to any project or direct query

Data Media Format
Excel / CSV
FLAT files
Company online portal

Aggregated reports (excel, ppt, flatfiles, etc.)
Local BI software

Number of Publications Using Database
0

Publications are pending. Please contact IQVIA for more information.

References of Studies Using/Describing Database

Publications are pending. Please contact IQVIA for more information.

    Database Contact
    Database Contact Data

    Email: RWDassets@iqvia.com

    Alternate Contact

    N/A

    References of Studies Using/Describing Database

    Publications are pending. Please contact IQVIA for more information.